G
GRI
GRI Bio
2.880
+0.590+25.76%After Hours: 2.625 -0.255 -8.87%19:58 09/04 EDT
OPEN/PREV CLOSE1.970/2.000
TODAY RANGE1.760-1.970
VOL201.65K
MARKET CAP3.94M
52 WEEK RANGE1.360-80.36
AVG VOL (3M)344.72K
% TURNOVER9.02%
TURNOVER--
P/E (TTM)-0.0348
% RANGE10.50%
EPS(TTM)-51.6532
P/E(FORWARD)-0.4358
P/B0.3828
BVPS4.702
DIVIDEND--
P/S476.19
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.92M
SHARES OUTSTANDING2.19M
NEXT EARNINGS11/12-11/16
FREE FLOAT2.18M
LOT SIZE1
EX-DATE01/26/2026
News
Press Releases
Financial Reports
Profile
Benzinga·1d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
TipRanks·1d ago
GRI Bio Reports Positive Phase 2a IPF Biomarker Data
Benzinga·5d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·6d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jones·08/24 09:54
GRI Bio Price Target Cut to $27.00/Share From $32.00 by Ascendiant Capital
Dow Jones·08/24 09:54
GRI Bio Is Maintained at Buy by Ascendiant Capital
Benzinga·08/11 17:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·07/20 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
TipRanks·06/18 23:11
GRI Bio Secures FDA Orphan Drug Status for IPF
TipRanks·06/18 13:05
GRI Bio announces U.S. FDA granted ODD to GRI-0621
TipRanks·06/17 15:00
GRI Bio granted FDA orphan designation for tazarotene
TipRanks·06/03 12:44
GRI Bio (GRI) Gets a Buy from Ascendiant
Benzinga·06/01 12:43
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know
Same Industry
Name/Symbol
Change%
Price